Crystal structure of stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases

Journal of Molecular Biology

Volumn 326, Issue 3, 2003, Pages 875-885

  Jenko, Saša ^a   Dolenc, Iztok ^a   Gunčar, Gregor ^a   Doberšek, Andreja ^a   Podobnik, Marjetka ^a   Turk, Dušan ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Aminopeptidase; Cystatin; Inhibitor; Lysosomal cysteine protease

Indexed keywords

AMINOPEPTIDASE; CATHEPSIN H; EXOPEPTIDASE; PAPAIN; PROTEINASE; STEFIN A;

AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; HUMAN; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

INSERTION SEQUENCES; SUIDAE;

EID: 0037459045     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)01432-8     Document Type: Article

References (53)

1. Dodt J., Rothe M. Studies on the aminopeptidase activity of rat cathepsin H. Eur. J. Biochem. 210:1992;759-764.
2. Turk B., Turk D., Turk V. Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta. 1477:2000;98-111.
3. Turk B., Turk D., Salvesen G. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Des. 8:2002;1623-1637.
4. Paoletti F., Mocali A., Tombaccini D. Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts. J. Cell. Physiol. 172:1997;63-68.
5. Hartz P.A., Wilson P.D. Functional defects in lysosomal enzymes in autosomal dominant polycystic kidney disease (ADPKD). Abnormalities in synthesis, molecular processing, polarity and secretion. Biochem. Mol. Med. 60:1997;8-26.
6. Turk V., Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Letters. 285:1991;213-219.
7. Turk B., Turk V., Turk D. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol. Chem. 378:1997;141-150.
8. Katunuma N., Kominami E. Distribution and localization of lysosomal cysteine proteases and cystatins. Turk V. Cysteine Proteinases and Their Inhibitors. 1986;219 Walter de Gruyter, Berlin.
9. Brzin J., Machleidt W., Borchart U., Fritz H., Ritonja A., Turk V. Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe-Seyler's Z. Physiol. Chem. 364:1983;1481-1486.
10. Barrett A.J., Rawlings N.D., Davies M.E., Machleidt W., Salvesen G., Turk V. Cysteine proteinase inhibitors of the cystatin superfamily. Barrett A.J., Salvesen G. Proteinase inhibitors. 1986;515 Elsevier, Amsterdam.
11. McKerrow J.H., Sun E., Rosenthal P.J., Bouvier J. The proteases and pathogenicity of parasitic protozoa. Annu. Rev. Microbiol. 47:1993;821-853.
12. Pennacchio L.A., Bouley D.M., Higgins K.M., Scott M.P., Noebels J.L., Myers R.M. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nature Genetics. 20:1998;251-258.
13. Lalioti M.D., Mirotsou M., Buresi C., Peitsch M.C., Rossier C., Ouazzani R., et al. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of Progressive Myoclonus Epilepsy (EPM1). Am. J. Hum. Genet. 60:1997;342-351.
14. Riccio M., Di Giamo R., Pianetti S., Palmieri P.P., Melli M., Santi S. Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp. Cell Res. 262:2001;84-94.
15. Kos J., Krašovec M., Cimerman N., Nielsen H.J., Christensen I.J., Brünner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relations to prognosis. Clin. Cancer Res. 6:2000;505-511.
16. Friedrich R., Jung K., Türk I., Rudolph B., Hampel G., Schnorr D., Loening S.A. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur. J. Cancer. 35:1999;138-144.
17. Zore I., Krašovec M., Cimerman N., Kuhelj R., Werle B., Nielsen H.J., et al. Cathepsin B/cystatin C complex levels in sera form patients with lung and colorectal cancer. Biol. Chem. 382:2001;805-810.
18. Cimerman N., Meško Brguljan P., Krašovec M., Šuškovič S., Kos J. Serum concentrations and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma. Clin. Chim. Acta. 310:2001;113-122.
19. Jones B., Roberts P.J., Faubion W.A., Kominami E., Gores G.J. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am. J. Physiol. 275:1998;G723-G731.
20. Dahl S.W., Halkier T., Lauritzen C., Dolenc I., Pedersen J., Turk V., Turk B. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry. 40:2001;1671-1678.
21. Bode W., Engh R., Musil D., Thiele U., Huber R., Karshikov A., et al. The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7:1988;2593-2599.
22. Stubbs M.T., Laber B., Bode W., Huber R., Jerala R., Lenarčič B., Turk V. The refined 2.4 Å X-ray structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 9:1990;1939-1947.
23. Gunčar G., Podobnik M., Pungerčar J., Štrukelj B., Turk V., Turk D. Crystal structure of porcine cathepsin H determined at 2,1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure. 6:1998;51-61.
24. Illy C., Quraishi O., Wang J., Purisima E., Vernet T., Mort J.S. Role of the occluding loop in cathepsin B activity. J. Biol. Chem. 272:1997;1197-1202.
25. Nycander M., Estrada S., Mort J.S., Abrahamson M., Björk I. Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop. FEBS Letters. 422:1998;61-64.
26. Pavlova A., Mort J.S., Abrahamson M., Björk I. Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110. FEBS Letters. 487:2000;156-160.
27. Cygler M., Sivaraman J., Grochulski P., Coulombe R., Storer A.C., Mort J.S. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion. Structure. 4:1996;405-416.
28. Podobnik M., Kuhelj R., Turk V., Turk D. Crystal structure of the wild-type human procathepsin B at 2.5 Å resolution reveals the native active site of a papain-like cysteine protease zymogen. J. Mol. Biol. 271:1997;774-788.
29. Machleidt W., Ritonja A., Popovič T., Kotnik M., Brzin J., Machleidt I. Human cathepsins B, H and L: characterization by amino acid sequences and some kinetics of inhibition by the kininogens. Turk V. Cysteine Proteinases and their Inhibitors. 1986;3 Walter de Gruyter, Berlin, New York.
30. Takahashi T., Dehdarani A.H., Schmidt P.G., Tang J. Cathepsins B and H from porcine spleen. Purification, polypeptide chain arrangements, and carbohydrate content. J. Biol. Chem. 259:1984;9874-9882.
31. Martin J.R., Jerala R., Kroon-Žitko, Žerovnik E., Turk V., Waltho J.P. Structural characterisation of human stefin A in solution and implications for binding to cysteine proteinases. Eur. J. Biochem. 225:1994;1181-1194.
32. Björk I., Ylinenjärvi K. Interaction of chicken cystatin with inactivated papains. Biochem. J. 260:1989;61-68.
33. Gunčar G., Pungerčič G., Klemenčič I., Turk V., Turk D. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 18:1999;793-803.
34. Auerswald E.A., Nägler D.K., Schulze A.J., Engh R.A., Geneger G., Machleidt W., Fritz H. Production, inhibitory activity, folding and coformational analysis of an N-terminal and an internal deletion variant of chicken cystatin. Eur. J. Biochem. 224:1994;407-415.
35. Estrada S., Olson S.T., Raub-Segall E., Björk I. The N-terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two-step binding by rapid-kinetic studies of cystatin A labeled at the N terminus with a fluorescent reporter group. Protein Sci. 9:2000;2218-2224.
36. Estrada S., Nycander M., Hill N.J., Craven C.J., Waltho J.P., Björk I. The Role of Gly-4 human cystatin a (stefin a) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin a gly-4 mutants with papain, cathepsin B and cathepsin L. Biochemistry. 37:1998;7551-7560.
37. Estrada S., Pavlova A., Björk I. The contribution of n-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain. cathepsin B and cathepsin L. Biochemistry. 38:1999;7339-7345.
38. Lenarčič B., Križaj I., Žunec P., Turk V. Differences in specificity for the interactions of stefins A. B and D with cysteine proteinases. FEBS Letters. 395:1996;113-118.
39. Cimerman N., Trstenjak-Prebanda M., Turk B., Popovič T., Dolenc I., Turk V. Interaction of cystatin C variants with papain and human cathepsins B, H and L. J. Enzyme Inh. 4:1999;167-174.
40. Jerala R., Žitko-Kroon L., Popovič T., Turk V. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H. FEBS. 224:1994;797-802.
41. Turk B., Dolenc I., Turk V. Dipeptidyl-peptidase I. Barrett A.J., Rawlings N.D., Woessner J.F. Jr. Handbook of Proteolytic Enzymes. 1998;631-634 Academic Press, London, UK.
42. Turk D., Janjič V., Štern I., Podobnik M., Lamba D., Dahl W.S., et al. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J. 20:2001;6570-6582.
43. Koga H., Mori N., Yamada H., Nishimura Y., Tokuda K., Kato K., Imoto T. Endo- and aminopeptidase activities of rat cathepsin H. Chem. Pharm. Bull. 40:1992;965-970.
44. Bevec T., Stoka V., Pungerčič G., Dolenc I., Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183:1996;1331-1338.
45. Turk V., Stoka V., Turk B., Lenarčič B. Properties, structure and interaction of lysosomal cysteine proteinases with their protein inhibitors cystatins. Ouali A. Expression of Tissue Proteinases and Regulation of Protein Degradation as Related to Meat Quality. 1995;199 ECCEAMST, Utrecht.
46. Kenig M., Jerala R., Kroon-Žitko L., Žerovnik E., Turk V. Major differences in stability and dimerization properties of two chimeric mutants of human stefins. Proteins: Struct. Funct. Genet. 42:2001;512-522.
47. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
48. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
49. Turk, D. (1992). Weiterentwicklung eines programms für molekülgraphik und elektrondichte-manipulation und seine anwendung auf verschiedene protein-strukturaufklärungen. PhD Thesis, Technische Universität, München.
50. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
51. Carson M. Ribbons 2.0. J. Appl. Crystallog. 24:1991;958-961.
52. Nicholls A., Sharp K.A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:1991;281-376.
53. Merritt E.A., Bacon D.J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524.